Detection of decreased penicillin susceptibility in viridans group streptococci

Pathology

Volumn 30, Issue 2, 1998, Pages 188-191

  Pottumarthy, Sudha ^a,b   Morris, Arthur J ^a  

^a NATIONAL WOMEN S HOSPITAL   (New Zealand)

^b GREEN LANE HOSPITAL   (New Zealand)

Author keywords

Disk diffusion method; Penicillin susceptibility; Viridans group streptococci

Indexed keywords

OXACILLIN; PENICILLIN G;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA MENINGITIDIS; NONHUMAN; STREPTOCOCCUS PNEUMONIAE;

EID: 0031898264     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313029800169216     Document Type: Article

References (17)

1. Bochud P-Y, Calandra T, Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med 1994; 97: 256-64.
2. Singh KP, Morris A, Lang SDR, MacCulloch DM, Bremner DA. Clinically significant Streptococcus anginosus (Streptococcus milleri) infections: a review of 186 cases. N Z Med J 1988; 101: 813-6.
3. Wilson WR, Karchmer, AW, Dajani AS, Taubert KA, Bayer A, Kaye D, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci and HACEK microorganisms. JAMA 1995; 274: 1706-13.
4. Carratalà J, Alcaide F, Fernàndez-Sevilla A, Corbella X, Linares J, Gudiol F. Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin Infect Dis 1995; 20: 1169-73.
5. Doern GV, Ferraro MJ, Brueggemann AB, Ruoff, KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996; 40: 891-1.
6. McWhinney PHM, Patel S, Whiley RA, Hardie JM, Gillespie SH, Kibbler CC. Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofioxacin. Antimicrob Agents Chemother 1993; 37: 2493-5.
7. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests - 5th edn; approved standard. NCCLS document M2-A5. Villanova, PA: NCCLS, 1993.
8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing - 6th informational supplement. NCCLS document M100-S6. Villanova, PA: NCCLS, 1995.
9. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests - 6th edn; approved standard. NCCLS document M2-A6. Wayne, PA: NCCLS, 1997.
10. Swenson JM, Hill BC, Thornsberry C. Screening pneumococci for penicillin resistance. J Clin Microbiol 1986; 24: 749-52.
11. Campos J, Trujillo G, Seuba T, Rodriguez A. Discriminative criteria for Neisseria meningitidis isolates that are moderately susceptible to penicillin and ampicillin. Antimicrob Agents Chemother 1992; 36: 1028-31.
12. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically - 4th edn; approved standard. NCCLS document M7-A4. Wayne, PA: NCCLS, 1997.
13. Hindler JA, Bruckner DA. MIC testing of viridans streptococci using E-test as compared to a reference method. In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy 1993; p. 254.
14. Rosser SJ, Alfa MJ, Hoban S, Kennedy J, Kabani A, Harding GKM. E-test vs. agar dilution susceptibility testing for viridans streptococc. In: Program and abstracts of the 96th General Meeting for American Society for Microbiology 1996; abstract C-183: p. 33.
15. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-3rd edn; approved standard. NCCLS document M7-A3. Villanova, PA: NCCLS, 1993.
16. Bantar C, Canigia LF, Relloso S, Lanza A, Bianchini H, Smayevsky J. Species belonging to the "Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens. J Clin Microbiol 1996; 34: 2020-2.
17. Jorgensen JH, Swenson JM, Tenover FC, Ferraro MJ, Hindler JA, Murray PR. Development of interpretative criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. J Clin Microbiol 1994; 32: 2448-59.